About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Trusted Messenger Intervention | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNANCT05167422

Trusted Messenger Intervention

The objective of this pilot study is to develop and evaluate test a trusted messenger intervention targeting vaccine hesitancy in patients on an inpatient psychiatric hospital setting with both acute ...

Lead sponsor: Dartmouth-Hitchcock Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Dartmouth-Hitchcock Medical Center

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Able and willing to give verbal informed consent to participate in the study or able to assent with guardian consent
•Expected to remain in the hospital for the duration of the study
•Mental health diagnosis Demographics

Exclusion Criteria

•Ages 18 or older
•Any race or ethnicity
•English speaking
•Cognitive impairment sufficient to interfere with participant's ability to provide assent
•People who are non-English speakers or who have major visual or hearing impairment will be excluded given the need to converse with the Trusted Messenger verbally
•People who have received any of the available forms of the COVID-19 vaccine, or those with a medical exemption for receiving the vaccine.

Related studies

Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups

NCT06639386 · Vaccine Hesitancy, Vaccine Refusal

Active Not RecruitingNA

Supporting CHWs as Vaccine Educators: Impact of a Digital Training and Chatbot Intervention on Vaccination in Kenya

NCT06237374 · Vaccine Knowledge, Vaccine Hesitancy, and more

Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia

NCT06505993 · COVID-19, Vaccine Hesitancy

Not Yet RecruitingNA

Effect of Primary Care Education on Parents' Health-Related Perceptions and Attitudes

NCT07381088 · Vaccine Hesitancy, Health Education, and more

Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos

NCT06156228 · Vaccine Hesitancy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 17, 2023Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment2

Start dateSep 2021

Last updatedJul 17, 2023

Condition

Vaccine Hesitancy

Locations shown

New Hampshire Hospital

Concord, New Hampshire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 17, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions